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Using linkage analysis, we identified a novel dominant locus, DFNA25, for delayed-onset, progressive, high-fre-
quency, nonsyndromic sensorineural hearing loss in a large, multigenerational United States family of Czech descent.
On the basis of recombinations in affected individuals, we determined that DFNA25 is located in a 20-cM region
of chromosome 12q21-24 between D12S327 (centromeric) and D12S84 (telomeric), with a maximum two-point
LOD score of 6.82, at recombination fraction .041, for D12S1030. Candidate genes in this region include ATP2A2,
ATP2B1, UBE3B, and VR-OAC. DFNA25 may be the human ortholog of bronx waltzer (bv).
Severe-to-profound sensorineural hearing impairment
occurs in 1 of 1,000 births in the United States (Morton
1991). For nearly four decades, it has been recognized
that 150% of cases of sensorineural hearing impairment
in children have a genetic etiology (Fraser 1964). In
∼70% of these cases, the hearing impairment is described
as “nonsyndromic,” because it is not associated with
other clinical manifestations (Bergstrom et al. 1971;
Konigsmark and Gorlin 1976). The genetic heteroge-
neity of this disorder has been well established, with 130
dominant hearing loss loci mapped to date (Hereditary
Hearing Loss home page). These loci are numbered se-
quentially, on the basis of time of discovery, and carry
the prefix “DFNA.” At present, 11 autosomal dominant
genes have been cloned (Hereditary Hearing Loss home
page).
Autosomal dominant nonsyndromic hearing loss
(ADNSHL) typically has a delayed (postlingual) onset,
and the hearing impairment becomes progressively
worse with age (Van Camp et al. 1997). The distinction
between presbycusis (hearing loss that commonly occurs
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with aging) and ADNSHL is often difficult when the
phenotype involves hearing loss in the high frequencies.
In addition, environmental noise exposure may cause
hearing loss, particularly affecting thresholds at 4,000
Hz.
The Institutional Review Board of the University of
Michigan Medical School approved the study, and ap-
propriate informed consent was obtained from all sub-
jects. A pedigree was constructed on the basis of infor-
mation obtained from questionnaires and interviews.
The clinical evaluation included an interview/question-
naire, photography, and pure-tone audiometry and
tympanometry.
All participants aged 127 mo underwent audiologic
testing by certified audiologists. Pure-tone air-conduc-
tion thresholds were obtained at 500, 1,000, 2,000,
4,000, and 6,000 Hz for each ear. When air-conduction
thresholds were 120 dB hearing level (HL), bone-con-
duction thresholds were obtained at 2,000 and 4,000
Hz, and tympanometry was performed.
To discriminate between hearing loss caused by the
DFNA25 locus and presbycusis or noise-induced hearing
loss, thresholds were compared with those of an unse-
lected control population (Robinson 1988). For pedi-
atric patients, thresholds were compared with data ob-
tained from unselected children (Haapaniemi 1996).
Patients were designated “affected” if they had a sen-
sorineural hearing impairment that was worse than the
90th percentile of sex- and age-matched subjects in the
control population (including those with presbycusis
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and/or noise exposure) for at least four thresholds. Those
with a history of noise exposure were not excluded from
the affected group if the above criteria were met. Af-
fected children were included in the linkage analysis,
whereas those aged !20 years without sensorineural
hearing loss were considered to have indeterminate af-
fection status. Family members aged 120 years with nor-
mal hearing or with hearing loss that was not worse
than the 90th percentile by these criteria were deemed
“unaffected.”
Peripheral lymphocytes obtained from the proband
were examined by the Cytogenetics Laboratory at the
University of Michigan Hospital, using standard kary-
otyping techniques. Venous blood samples were ob-
tained from consenting family members. For young fam-
ily members and those from whom blood could not be
drawn, buccal-cell samples were obtained. Genomic
DNA was prepared from leukocytes or buccal cells ac-
cording to standard methods.
The DNA samples underwent a genome scan by the
National Heart, Lung, and Blood Institute’s Mammalian
Genotyping Service (MGS). The genome scan used the
Marshfield Screening Set 9, consisting of 387 polymorphic
markers, at 10-cM average spacing, with average hetero-
zygosity of 73% (Yuan et al. 1997). The MGS required
that the known dominant loci (DFNA1-20) be excluded
by linkage analysis prior to submission of the samples.
After the genome scan, genotyping of family samples was
performed as described elsewhere (Lesperance et al. 1995)
for 4 markers in the Marshfield Screening Set 9
(D12S1064, D12S1300, PAH, and D12S2070) and for
10 markers selected from the Marshfield chromosome 12
map (D12S1684, D12S2077, D12S327, D12S1051,
D12S1063, D12S1607, D12S1030, D12S84, D12S1583,
and D12S1341) (Broman et al. 1998).
Alleles were sized by genotyping of individuals 1331-
01 and 1331-02 from the CEPH pedigrees (CEPH/Ge´-
ne´thon). The marker allele frequencies were determined
by genotyping 19 unrelated spouses in the pedigree. To
avoid overstated evidence for linkage caused by under-
estimation of marker allele frequencies, the allele fre-
quency for the linked allele was not allowed to be !.1.
The standard model for analysis assumed a disease allele
frequency (GF) of .00001, with 0% phenocopy rate (PC)
and penetrance (P) of 90%. Four additional models were
tested: , , ;GFp .00001 PCp .001 Pp 90% GFp
, , ; , ,.01 PCp .001 Pp 90% GFp .01 PCp 0 Pp
; and , , . The two-90% GFp .00001 PCp 0 Pp 1%
point LOD scores, recombination fraction (v), and max-
imum LOD scores (Zmax) were then calculated by means
of the MLINK and ILINK programs from the LINKAGE
package (Lathrop et al. 1984).
The pedigree, demonstrating 51 family members in-
formative for linkage analysis, is shown in figure 1. Clin-
ical evaluation did not reveal any evidence of syndromic
features associated with the hearing impairment, and
karyotype results were normal. Several affected and un-
affected family members had a history of noise exposure.
Affected family members had a nonsyndromic, slowly
progressive, sensorineural hearing impairment. The fre-
quencies most commonly affected were 2,000 Hz.
Twenty family members were deemed affected, 9 were
spouses of affected family members, and 22 were un-
affected. The age at onset appeared to vary within the
family. Ten affected family members either suspected
hearing loss prior to age 20 years or had such hearing
loss diagnosed during this study. The remaining 10 af-
fected family members had hearing loss diagnosed in the
third through sixth decades of life.
The calculated allele frequencies were comparable to
those reported in the CEPH and Cooperative Human
Linkage Center genotype databases, although some of
the alleles in our population were not found in these
genotype databases. No evidence of linkage was ob-
served for 383 of 387 markers tested in the genome
screen. Linkage was first detected to a polymorphic
marker within intron 3 of the phenylalanine hydroxylase
gene (PAH [MIM 261600]), chromosome 12q21-q24,
which ultimately yielded Zmax 6.24 at .vp .05
The haplotype analysis demonstrated evidence of re-
duced penetrance (fig. 1). Individuals III:9 and III:10 are
siblings tested at ages 61 and 60 years, respectively, but
neither had hearing loss that met criteria for affected
status. Both had a history of noise exposure, with III:
10 having two thresholds that were worse than or near
the 90th percentile cutoff and III:9 having only one sig-
nificantly abnormal threshold (75th percentile). In sum-
mary, although both siblings inherited a significant part
of the haplotype common to the affecteds, neither’s hear-
ing is worse than would be expected from presbycusis
or noise exposure alone. Thus, the penetrance was not
assumed to be complete at any age in this family, and
recombination events in unaffected individuals were not
used to define the DFNA25 interval.
Individual III:11 was classified as affected on the basis
of our criteria. However, only D12S1684 indicates that
III:11 definitely inherited the allele common to the af-
fecteds, since marker D12S1064 is uninformative. III:11
reported a significant history of occupational noise ex-
posure and was first diagnosed with hearing loss at age
37 years. He has worn bilateral hearing aids since that
time, and his hearing is generally more severely affected
than that of other family members of similar age. All
three of his children have normal hearing. Since indi-
vidual III:11 essentially lacks the haplotype shared by
the affecteds, we conclude that he is most likely a phe-
nocopy. However, on the basis of his phenotype, as-
signed prior to the genetic analysis, he is classified as
affected in the LOD score calculations.
Two affected recombinant individuals (III:19 and III:
Figure 1 Haplotype analysis of DFNA25 family with nonsyndromic high-frequency sensorineural hearing impairment. Circles and squares denote females and males, respectively. Diagonal lines
through circles and squares indicate deceased individuals, and inferred alleles are in parentheses. Blackened symbols indicate affected persons, whereas unblackened symbols indicate unaffected persons.
Haplotypes for chromosome 12 markers are indicated at the left of the figure, with obligate recombination events indicated. The haplotype assumed to carry the disease allele is indicated by the
black bar, with other shadings representing the other haplotypes. Lines in haplotypes represent indeterminate recombination events.
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Figure 2 Ideogram of chromosome 12q, indicating analyzed
markers in bands 12q21-24 and DFNA25 interval. Distances between
markers were obtained from the Marshfield Center for Medical Ge-
netics. The blackened portions of the bars indicate informative recom-
bination events. The number of affected individuals with each type of
crossover is indicated at the bottom of each bar.
22) and their offspring define the centromeric end of the
interval. Obligate recombination events have occurred
between D12S327 and D12S1051 in individuals III:19,
IV:13, IV:15, and V:1. A second recombination event
can be inferred at marker D12S1684 for individual IV:
15. III:22 and IV:21 are affected individuals with obli-
gate recombination events between D12S2077 and
D12S327. A second recombination event has occurred
between D12S1063 and D12S1607 in IV:20, who had
normal hearing when tested at age 31 years. IV:24 has
inherited the haplotype common to the affecteds, except
for a recombination event excluding D12S1684; when
tested at age 27 years, she was considered unaffected,
since she had only one abnormal threshold.
The telomeric end of the interval is defined by indi-
vidual III:13, an affected with a recombination event
excluding markers D12S84, D12S1583, D12S1341, and
D12S2070. His daughter, IV:10, inherited the same por-
tion of the affecteds’ haplotype; she is 37 years old with
normal hearing. Affected individual III:20 and his af-
fected offspring IV:18 are nonrecombinant for D12S84
but are recombinant for D12S1583, D12S1341, and
D12S2070. IV:16 inherited the same recombinant hap-
lotype as her parent III:20; IV:16 is 45 years old, with
normal hearing, except for one abnormal threshold. A
recombination event occurred between D12S327 and
D12S1051 in individual IV:17, who had normal hearing
when tested at age 40 years. Multiple affected individ-
uals (III:3, III:4, III:7, IV:3, IV:4, IV:23, and V:2) inher-
ited the same recombinant chromosome excluding mark-
ers D12S1341 and D12S2070. In summary, the interval
defined by affected recombinants at D12S327 (centrom-
eric) and D12S84 (telomeric) spans 20 cM in 12q21-24
(fig. 2).
LOD scores for 14 markers are shown in table 1.
Under the standard model, a maximum two-point LOD
score of 6.82 was observed at for D12S1030.vp .041
A LOD score of 5.04 was observed at forvp 0
D12S1051, since the affected parent (II:3) of the affected
recombinant III:11 is presumed to be homozygous for
the linked allele. Otherwise, LOD scores at tendedvp 0
to be negative for all markers, because of the effects of
classifying a likely phenocopy (III:11) as affected and
unaffected family members carrying the linked allele.
Zmax and the maximum-likelihood estimate of v ( ) didˆv
not change significantly under the different models
tested, with the exception of a lower Zmax under the
model with penetrance of 1% (data not shown).
It has been increasingly recognized that genotype does
not completely predict phenotype, even for classic “sim-
ple” Mendelian traits such as the autosomal dominant
hearing loss segregating in this family (Dipple and
McCabe 2000). Phenotypes may vary widely between
individuals with different mutations in the same gene
and even between individuals in the same family who
have inherited the identical mutation. It is hypothesized
that other genetic factors (such as nonallelic polymor-
phisms) or environmental influences can modulate the
effect of a genetic mutation on the phenotype. Restrict-
ing the definition of affected status to those most severely
affected and/or those with early onset may facilitate link-
age analysis by enriching for those who have the disorder
because of the genetic factor.
However, in this family, two individuals with hearing
loss consistent with presbycusis (III:9 and III:10, aged
61 and 60 years, respectively) carry a significant portion
of the haplotype shared by the affecteds. In addition, a
45-year-old woman (IV:16) who is presumed to have
inherited the mutated gene has essentially normal hear-
ing. Because some affected family members first became
aware of their hearing loss as late as the sixth decade
of life, retests of unaffected individuals several years
from now may eventually reveal the onset of hearing
loss. It is interesting to note that examples of incomplete
penetrance appear to be clustered within certain sibships
(III:9 and III:10; IV:16 and IV:17 and cousin IV:20),
suggesting that other genetic factors or “modifier genes”
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Table 1
Two-Point LOD Scores for Chromosome 12 Markers, Calculated under a Model of
90% Penetrance, Disease Allele Frequency .00001, and Phenocopy Rate 0
LOCUS
LOD SCORE AT v p
ˆv Zmax0 .01 .05 .1 .2 .3 .4
D12S1684 14.94 2.99 .17 1.42 2.13 1.86 1.02 .212 2.14
D12S1064 3.24 3.27 3.28 3.17 2.68 1.97 1.07 .033 3.29
D12S2077 5.50 2.35 .09 .80 1.27 1.01 .46 .202 1.27
D12S327 3.68 1.67 2.93 3.23 2.94 2.12 1.01 .113 3.24
D12S1051 5.04 4.96 4.62 4.18 3.26 2.26 1.17 0 5.04
D12S1300 .39 2.99 3.66 3.75 3.26 2.30 1.06 .088 3.76
D12S1063 2.49 3.52 4.16 4.22 3.67 2.66 1.34 .081 4.24
D12S1607 4.06 3.72 4.26 4.23 3.57 2.50 1.17 .068 4.29
PAH 1.64 5.83 6.24 6.04 5.02 3.55 1.76 .05 6.24
D12S1030 1.18 6.51 6.81 6.51 5.33 3.75 1.86 .041 6.82
D12S84 1.89 4.52 5.55 5.58 4.78 3.45 1.75 .076 5.63
D12S1583 1.99 2.43 4.10 4.40 3.93 2.86 1.46 .103 4.40
D12S1341 14.70 1.372 1.79 2.78 3.02 2.38 1.28 .166 3.08
D12S2070 14.79 2.41 .89 2.01 2.45 1.96 .97 .184 2.46
may influence the expression of the phenotype. Con-
versely, once the responsible gene is identified, it is also
possible that III:9 and III:10 will be found to carry the
same mutation as is carried by other affected family
members. If that is the case, the phenotype of the un-
derlying mutation overlaps with presbycusis, and our
criteria for affected status may have been too restrictive.
Database searches revealed numerous genes in the re-
gion that are known to be expressed in the ear. More
than 30 expressed sequence tags map within the
DFNA25 candidate-gene interval (Schuler et al. 1996;
Skvorak et al. 1999; Unigene electronic updates). The
proximal portion of the interval corresponds to mouse
chromosome 10, whereas distal 12q24 corresponds to
mouse chromosome 5. No mouse mutant with nonsyn-
dromic deafness has yet been mapped to that interval
on mouse 10; however, bronx waltzer (bv), mapping to
mouse 5, may be a model for DFNA25 (Bussoli et al.
1997).
ATP2A2 [MIM 108740] and ATP2B1 [MIM 108731]
both encode calcium channels and map to the DFNA25
interval (Olson et al. 1991; Sakuntabhai et al 1999). A
related gene, Atp2b2 [MIM 108733], also known as
Pmca2, encodes a plasma membrane calcium–ATPase
type 2 pump known to be mutated in deafwaddler (dfw)
mice (Street et al. 1998). Mutations in ATP2A2 cause
Darier–White disease (DAR [MIM 124200]), a derma-
tologic disorder (Sakuntabhai et al. 1999). Although
deafness is not part of the Darier phenotype, this gene’s
role is thought to be analogous to that of connexin 26
(GJB2 [MIM 121011]) and connexin 31 (GJB3 [MIM
603324]) in intercellular communication between epi-
dermal cells. GJB2 and GJB3 are known causes of non-
syndromic deafness as well as dermatologic disorders
(Kelsell et al. 1997; Richard et al. 1998; Xia et al. 1999).
Two genes expressed in the basilar papilla of the chick
are known to map to BACs (Human Genome Sequenc-
ing Center, Baylor College of Medicine) in the DFNA25
interval. UBE3B is a novel E3 ubiquitin ligase identified
by upregulation of its mRNA immediately after noise
exposure in the chick (Gong et al. 1996) and is known
to be expressed in human fetal cochlea (Lomax et al.,
in press). VR-OAC (vanilloid receptor–related osmoti-
cally activated channel) is a novel calcium channel gene
(Liedtke et al. in press).
The human ortholog of a novel zinc finger gene zfOC1,
cloned from a guinea pig organ of Corti library, has been
mapped to 12q24.3 (Rivolta et al. 1996). Other genes
that map unambiguously within the interval include al-
dehyde dehydrogenase 2 (ALDH2 [MIM 100650]), B-cell
translocation gene 1 (BTG1 [109580]), decorin (DCN
[MIM 125255]), insulin-like growth factor 1 (IGF1 [MIM
147440]), leukotriene A4 hydrolase (LTA4H [MIM
151570]), mast cell growth factor (MGF [MIM 184745])
phenylalanine hydroxylase (PAH [MIM 261600], spi-
nocerebellar ataxia 2 (SCA2 [MIM 183090]), and thio-
redoxin reductase 1 (TXNRD1 [MIM 601112]).
In summary, a novel locus for nonsyndromic senso-
rineural hearing impairment, DFNA25, has been
mapped to 12q21-24. Because the phenotype is similar
to presbycusis, this locus should be considered as a can-
didate region for presbycusis in the general population.
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